参考文献/References:
[1] Nogi T,Yasui N,Mihara E,et al.Structural basis for semaphorin signalling through the plexin receptor[J].Nature,2010,467(7319):1123-1127.DOI:10.1038/nature09473.
[2] Liang Y,Wang W,Huang J,et al.Potential role of semaphorin 3A and its receptors in regulating aberrant sympathetic innervation in peritoneal and deep infiltrating endometriosis[J].PLoS One,2015,10(12):e0146027.DOI:10.1371/journal.pone.0146027.
[3] Hayashi M,Nakashima T,Taniguchi M,et al.Osteoprotection by semaphorin 3A[J].Nature,2012,485(7396):69-74.DOI:10.1038/nature11000.
[4] Movassagh H,Tatari N,Shan L,et al.Human airway smooth muscle cell proliferation from asthmatics is negatively regulated by semaphorin3A[J].Oncotarget,2016,7(49):80238-80251.DOI:10.18632/oncotarget.12884.
[5] Tufro A. Semaphorin3a signaling, podocyte shape, and glomerular disease[J].Pediatr Nephorol,2014,29(4):751-755.DOI:10.1007/s00467-013-2743-x.
[6] Neufeld G,Mumblat Y,Smolkin T,et al.The semaphorins and their receptors as modulators of tumor progression[J].Drug Resist Updat,2016,29:1-12.DOI:10.1016/j.drup.2016.08.001.
[7] Plein A,Calmont A,Fantin A,et al. Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tractseptation[J].J Clin Invest,2015,125(7):2661-2676.DOI:10.1172/JCI79668.
[8] Valdembri D,Regano D,Maione F, et al. Class 3 semaphorins in cardiovascular development[J].Cell Adh Migr,2016,10(6):641-651.DOI:10.1080/19336918.2016.1212805.
[9] Janssen BJ,Malinauskas T,Weir GA,et al.Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex[J].Nat Struct Mol Biol,2012,19(12):1293-1299.DOI:10.1038/nsmb.2416.
[10] Worzfeld T,Swiercz JM,Sentürk A,et al.Genetic dissection of plexin signaling in vivo[J].Proc Natl Acad Sci U S A,2014,111(6):2194-2199.DOI:10.1073/pnas.1308418111.
[11] Johnson AM,Olefsky JM.The origins and drivers of insulin resistance[J].Cell,2013,152(4):673-684.DOI:10.1016/j.cell.2013.01.041.
[12] Glass CK,Olefsky JM.Inflammation and lipid signaling in the etiology of insulin resistance[J].Cell Metab,2012,15(5):635-645.DOI:10.1016/j.cmet.2012.04.001.
[13] Takamatsu H,Kumanogoh A.Diverse roles for semaphorin-plexin signaling in the immune system[J].Trends Immunol,2012,33(3):127-135.DOI:10.1016/j.it.2012.01.008.
[14] Shimizu I,Yoshida Y,Moriya J,et al.Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity[J].Cell Metab,2013,18(4):491-504.DOI:10.1016/j.cmet.2013.09.001.
[15] Forbes JM,Cooper ME.Mechanisms of diabetic complications[J].Physiol Rev,2013,93(1):137-188.DOI:10.1152/physrev.00045.2011.
[16] Reidy KJ,Aggarwal PK,Jimenez JJ,et al.Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction[J].Am J Pathol,2013,183(4):1156-1168.DOI:10.1016/j.ajpath.2013.06.022.
[17] Mohamed R,Ranganathan P,Jayakumar C,et al.Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice[J].J Mol Med(Berl),2014,92(12):1245-1256.DOI:10.1007/s00109-014-1209-3.
[18] Aggarwal PK,Veron D,Thomas DB,et al. Semaphorin3a promotes advanced diabetic nephropathy[J].Diabetes,2015,64(5):1743-1759.DOI:10.2337/db14-0719.
[19] Kwon SH,Shin JP,Kim IT,et al.Association of plasma semaphorin 3A with phenotypes of diabetic retinopathy and nephropathy[J].Invest Ophthalmol Vis Sci,2016,57(7):2983-2989.DOI:10.1167/iovs.16-19468.
[20] Ishibashi R,Takemoto M,Akimoto Y,et al.A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation[J].Sci Rep,2016,6:25955.DOI:10.1038/srep25955.
[21] Joyal JS,Sitaras N,Binet F,et al.Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A[J].Blood,2011,117(22):6024-6035.DOI:10.1182/blood-2010-10-311589.
[22] Fukushima Y,Okada M,Kataoka H,et al.Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice[J].J Clin Invest,2011,121(5):1974-1985.DOI:10.1172/JCI44900.
[23] Kwon SH,Shin JP,Kim IT,et al.Aqueous levels of angiopoietin-like 4 and semaphorin 3E correlate with nonperfusion area and macular volume in diabetic retinopathy[J].Ophthalmology,2015,122(5):968-975.DOI:10.1016/j.ophtha.2015.01.007.
[24] Cerani A,Tetreault N,Menard C,et al.Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1[J].Cell Metab,2013,18(4):505-518.DOI:10.1016/j.cmet.2013.09.003.
[25] Sharma A,LeVaillant CJ,Plant GW,et al.Changes in expression of class 3 semaphorins and their receptors during development of the rat retina and superior colliculus[J].BMC Dev Biol,2014,14:34.DOI:10.1186/s12861-014-0034-9.
[26] Buehler A,Sitaras N,Favret S,et al.Semaphorin 3F forms an anti-angiogenic barrier in outer retina[J].FEBS Lett,2013,587(11):1650-1655.DOI:10.1016/j.febslet.2013.04.008.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(02):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(02):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(02):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(02):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(02):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(02):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(02):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(02):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(02):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]